Envista Holdings Corporation (NVST) stock analysis

NVST · Envista Holdings Corporation

Latest recorded price: USD 24.03

Model-estimated fair value: USD 30.47. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Medical Instruments & Supplies

At $24.03, NVST trades 21.1% below the model's base-case value of $30.47. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $23.98 in the conservative case and $37.73 in the optimistic case, with a valuation confidence score of 55/100. About 74% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 1.9%, free cash flow margin 8.5%, ROIC 5.1%. The model flags 1 risk signal for this company.

Similar companies in Healthcare